These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2484943)

  • 21. Pharmacology of neurokinin receptors.
    Regoli D; Nantel F
    Biopolymers; 1991 May; 31(6):777-83. PubMed ID: 1718474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concepts in characterization of tachykinin receptors.
    Burcher E; Mussap CJ; Geraghty DP; McClure-Sharp JM; Watkins DJ
    Ann N Y Acad Sci; 1991; 632():123-36. PubMed ID: 1719861
    [No Abstract]   [Full Text] [Related]  

  • 23. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism.
    Kavelaars A; Jeurissen F; von Frijtag Drabbe Künzel J; Herman van Roijen J; Rijkers GT; Heijnen CJ
    J Neuroimmunol; 1993 Jan; 42(1):61-70. PubMed ID: 7678598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of substance P and other tachykinins on inositol phospholipid hydrolysis in rabbit retina, superior colliculus and retinal cultures.
    Osborne NN; Ghazi H
    Vision Res; 1989; 29(7):757-64. PubMed ID: 2483005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells.
    Gallicchio M; Benetti E; Rosa AC; Fantozzi R
    Inflamm Res; 2008; 57 Suppl 1():S17-8. PubMed ID: 18345509
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.
    Haines KA; Kolasinski SL; Cronstein BN; Reibman J; Gold LI; Weissmann G
    J Immunol; 1993 Aug; 151(3):1491-9. PubMed ID: 7687633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of NK1 receptors and importance of the N-terminal sequence of substance P in the stimulation of protein secretion in rat parotid glands.
    Rollandy I; Guillemain I; Imhoff V; Drapeau G; Regoli D; Rossignol B
    Eur J Pharmacol; 1991 Dec; 209(1-2):95-100. PubMed ID: 1726089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SR 140333 and SR 48968 on antigen and substance P-induced activation of guinea-pig alveolar macrophages.
    Boichot E; Germain N; Emonds-Alt X; Advenier C; Lagente V
    Clin Exp Allergy; 1998 Oct; 28(10):1299-305. PubMed ID: 9824398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel regulatory mechanisms of IgA synthesis: respective roles of neuropeptides and cells of the anti-suppressor circuit.
    Ernst PB; Stanisz AM; Scicchitano R; Paraskevas F; Payan D; Bienenstock J
    Adv Exp Med Biol; 1987; 216A():57-68. PubMed ID: 2446471
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of substance P receptors in human astrocytoma cells.
    Johnson CL; Johnson CG; Stauderman KA; Buck SH
    Ann N Y Acad Sci; 1991; 632():410-2. PubMed ID: 1719890
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line.
    Krumins SA; Broomfield CA
    Neuropeptides; 1992 Feb; 21(2):65-72. PubMed ID: 1372967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P selectively activates TNF-alpha gene expression in murine mast cells.
    Ansel JC; Brown JR; Payan DG; Brown MA
    J Immunol; 1993 May; 150(10):4478-85. PubMed ID: 7683320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Localization and physiologic role of neuropeptides and their receptors--the tachykinin family of substance P, neurokinin A and neurokinin B].
    Kimura S
    Nihon Rinsho; 1990 May; 48(5):962-8. PubMed ID: 1695954
    [No Abstract]   [Full Text] [Related]  

  • 35. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis.
    Bot I; de Jager SC; Bot M; van Heiningen SH; de Groot P; Veldhuizen RW; van Berkel TJ; von der Thüsen JH; Biessen EA
    Circ Res; 2010 Jan; 106(1):89-92. PubMed ID: 19926877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of substance P in inflammatory arthritis.
    Garrett NE; Mapp PI; Cruwys SC; Kidd BL; Blake DR
    Ann Rheum Dis; 1992 Aug; 51(8):1014-8. PubMed ID: 1384440
    [No Abstract]   [Full Text] [Related]  

  • 37. The extracellular domain of substance P (NK1) receptor comprises part of the ligand binding site.
    Fong TM; Yu H; Strader CD
    Biophys J; 1992 Apr; 62(1):59-60. PubMed ID: 1376175
    [No Abstract]   [Full Text] [Related]  

  • 38. Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor.
    Hamke M; Herpfer I; Lieb K; Wandelt C; Fiebich BL
    Brain Res; 2006 Aug; 1102(1):135-44. PubMed ID: 16806114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 5-hydroxytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro.
    Joos GF; Lefebvre RA; Bullock GR; Pauwels RA
    Eur J Pharmacol; 1997 Nov; 338(3):259-68. PubMed ID: 9424020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of neuropeptides, nerves and mast cells in intestinal immunity and physiology.
    Bienenstock J; Denburg J; Scicchitano R; Stead R; Perdue M; Stanisz A
    Monogr Allergy; 1988; 24():134-43. PubMed ID: 2452344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.